![Steven Ketchum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Ketchum
Technik-/Wissenschafts-/F&E-Leiter bei
AMARIN CORPORATION PLC
Vermögen: 12 Mio $ am 31.05.2026
Profil
Steven B. Ketchum is Chief Scientific Officer, EVP, President-R&D at Amarin Corp.
Plc since 2012.
Formerly, Dr. Ketchum was Senior Director-Regulatory Affairs at ALZA Corp.
from 1994 to 2002, Senior VP-Operations & Regulatory Affairs at IntraBiotics Pharmaceuticals, Inc. from 2002 to 2007, Senior VP-Medical Affairs, Research & Development at Reliant Pharmaceuticals LLC from 2005 to 2008, and Independent Director at Sunesis Pharmaceuticals, Inc. from 2012 to 2021.
Education includes undergraduate studies at Stanford University and a doctorate from University College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 817’580 ( 0.2% ) | 12 Mio $ | 31.05.2026 | |
| 31.01.2025 | 37’350 ( 0.18% ) | 541 202 $ | 31.05.2026 |
Aktive Positionen von Steven Ketchum
| Unternehmen | Position | Beginn |
|---|---|---|
| AMARIN CORPORATION PLC | Technik-/Wissenschafts-/F&E-Leiter | 16.02.2012 |
Ehemalige bekannte Positionen von Steven Ketchum
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2012 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2008 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Geschäftsführer | 22.01.2007 |
| ALZA CORPORATION | General Counsel | 01.05.2002 |
Ausbildung von Steven Ketchum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
